On the other hand, mRNA levels of ROR2, NFKBIA, DUSP6, PLCB3, and SMAD4 are lower in metastatic prostate tumors as compared to primary prostate tumors (Figures 6–8). This evidence concerns the gene PLCB3 and prostate neoplasm.